Application

17820818 · ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

Filed 2022-08-18 · Abandoned The official file ↗ · Art unit 1643 · Examiner Stephen L Rawlings Typical · CPC C07K 16/2809 · Marengo Therapeutics, Inc. · WILSON SONSINI GOODRICH & ROSATI

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

6.4 mo

to disposition 25.1 mo

Statutes raised

112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.